Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 9—September 2024
Research
Effects of Rotavirus Vaccination Coverage among Infants on Hospital Admission for Gastroenteritis across All Age Groups, Japan, 2011–2019
Kenji Kishimoto, Susumu Kunisawa, Kiyohide Fushimi, and Yuichi Imanaka
Table 1
Characteristics of gastroenteritis patients in study of effects of rotavirus vaccination coverage among infants on hospital admission for gastroenteritis across all age groups, Japan, 2011–2019*
| Characteristic |
Value |
|---|---|
| Overall no. patients |
294,108 |
| Median age, y (IQR) | 41 (9–73) |
| Age group, y | |
| <5 | 51,501 (17.5) |
| 5–19 | 47,570 (16.2) |
| 20–59 | 82,392 (28.0) |
| ≥60 |
112,645 (38.3) |
| Immunocompromised patients |
38,058 (12.9) |
| Underlying conditions | |
| Cancer | 23,948 (8.1) |
| HIV infection |
120 (0.04) |
| Medication | |
| Steroids | 17,276 (5.9) |
| Immunosuppressants |
3,459 (1.2) |
| Median stay, d (IQR) | 5 (3–9) |
*Values are no. (%) patients except as indicated. IQR, interquartile range
Page created: July 31, 2024
Page updated: August 13, 2024
Page reviewed: August 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.